BRIEF-Aralez resubmits NDA for Yosprala to FDA

Tue Mar 15, 2016 9:18am EDT
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

March 15 (Reuters) - Aralez Pharmaceuticals Inc

* Aralez resubmits to FDA New Drug Application for Yosprala

* FDA is expected to issue Aralez an acknowledgment letter within 30 days of resubmission

* If accepted, acknowledgement would also include a new Prescription Drug User Fee Act date Source text for Eikon: Further company coverage: